Inorganic Chemistry
Article
C40H34F6N4O6P2S2: C 52.98, H 3.78, N 6.18; found: C 51.92, H 3.83,
N 5.85.
(t, JCP = 23.9, C), 133.5 (t, JCP = 23.9, C), 132.7 (s, CHar), 132.0 (s,
CHar), 131.9 (s, CHar), 131.7 (s, CHar), 131.6 (d, JCP = 7.5, CHar), 131.1
(t, JCP = 6.3, CHar), 130.8 (s, CHar), 129.1 (t, JCP = 5.0, CHar), 128.9 (t,
JCP = 5.0, CHar), 128.8 (s, CHar), 124.9 (s, CHar), 124.8 (s, CHar), 124.5
(s, CHar), 123.3 (s, CHar), 123.2 (s, CHar), 123.1 (s, CHar), 121.6 (s,
CHar), 121.4 (s, CHar), 120.8 (q, JCF = 321.8, CF3SO3), 55.0 (s, CH3O),
36.8 (s, CH3N), 36.7 (s, CH3N). 31P NMR (CD2Cl2, 25 °C):δ = +124.9
(d, JPRh = 143.8). 103Rh NMR (CD3CN, 25 °C): δ = −255 ppm.
Rhodium(I) Chloride Complexes of the Ligand 3 (4, 5). A
mixture of [RhCl(cod)]2 (163 mg, 0.33 mmol) and dication 3 (500 mg,
0.55 mmol) was dissolved in CH2Cl2 (20 mL) at −40 °C, and stirred at
room temperature for 12 h. After evaporation of the solvent, the crude
residue was washed with Et2O (30 mL) affording 4 as a yellow powder
(572 mg, 90%; mp 216−218 °C). Then complex 4 was dissolved in
CH2Cl2 (10 mL), and carbon monoxide was bubbled for 30 min at room
temperature. After evaporation of the solvent, and washing with
Et2O (20 mL), 5 was obtained as a yellow powder (404 mg, 76%).
Recrystallization from MeCN/Et2O at 0 °C afforded 5 as orange crystals
(mp 112−113 °C).
−
MS(ES+): m/z 951.1 [M − CF3SO3 ]+; HRMS(ES+) calcd for
C42H41N4O6F3P2SRh, 951.1229; found, 951.1255. Elemental analysis,
calcd (%) for C43H41F6N4O9P2RhS2: C 46.92, H 3.75, N 5.09; found: C
45.62, H 3.27, N 5.07.
Crystal Structure Determination of Compounds 2, 3, and 5.
Intensity data for compounds 2, 3, and 5 were collected at 180 K on an
Apex2 Bruker diffractometer using a graphite-monochromated Mo Kα
radiation source and equipped with an Oxford Cryosystems Cryostream
Cooler Device. Structures were solved using SIR9224 or SUPERFLIP,25
and refined by full-matrix least-squares procedures on F using the
programs of the PC version of CRYSTALS.26 Atomic scattering factors
were taken from the International tables for X-ray Crystallography.27
All non-hydrogen atoms were refined anisotropically. Hydrogen atoms
were refined using a riding model. Absorption corrections were
introduced using the program MULTISCAN.28 For 3, the crystal was
of poor quality (a phenyl group is disordered). Refinement of the used
model led to a satisfactory solution with a 0.5:0.5 occupancy ratio. It was
not possible to resolve diffuse electron-density residuals (enclosed
solvent molecules). Finally, treatment with the SQUEEZE29 facility
from PLATON30 resulted in a better refinement.
RhCl(cod)[3] Complex (4). 1H NMR (CDCl3, 25 °C): δ = 7.77−
7.16 (m, 28H, Har), 5.70 (br, 2H, CHcod), 4.55 (br, 2H, CHcod), 3.71 (s,
6H, NCH3), 2.43 (brs, 4H, CH2cod), 2.14 (brs, 4H, CH2cod). 13C NMR
(CDCl3, 25 °C): δ = 140.9 (d, JCP = 23.6, C), 135.3 (s, C), 132.9 (s,
CHar), 130.1 (s, CHar), 129.8 (s, CHar), 128.8−124.5 (m, C, CHar),
120.7 (q, JCF = 320.8, CF3SO3), 107.8 (s, CHcod), 73.0 (br, CHcod), 39.5
(CH3), 32.8 (s, CH2cod), 28.7 (s, CH2cod). 31P NMR (CDCl3, 25 °C):
δ = +26.4 (d, JPRh = 150.4). 103Rh NMR (CDCl3, 25 °C): δ = +379
−
ppm. MS(ES+): m/z 1003.1 [M-CF3SO3 ]+; HRMS(ES+) calcd for
C47H46ClN4O3F3P2SRh: 1003.1462; found: 1003.1458.
RhCl(CO)[3] Complex (5). 1H NMR (CD3CN, 25 °C): δ = 8.70 (s,
1H, Har), 8.10 (d, 2H, JHH = 5.0, Har), 7.87 (d, 2H, JHH = 5.0, Har), 7.83−
7.42 (m, 23H, Har), 3.30 (s, 6H, NCH3). 13C NMR (CD3CN, 25 °C):
δ = 182.9 (td, JCRh = 74.2, JCP = 15.1, CO), 140.6 (t, J = 13.8, C), 135.4
(s, CHar), 134.8 (s, C), 133.0 (s, CHar), 132.7 (d, JCP = 6.3, CHar), 132.6
(d, JCP = 6.3, CHar), 130.0 (s, CHar), 129.8 (t, JCP = 5.0, CHar), 129.6 (s,
CHar), 129.3 (t, JCP = 5.0, CHar), 129.1 (s, CHar), 127.7 (s, CHar), 126.7
Crystal data for 2: C36H28N4P2, M = 578.59 g·mol−1, Monoclinic, a =
10.1714(8), b = 20.5363(13), c = 15.1935(9) Å, β = 109.556(3)°, V =
2990.6(4) Å3, T = 180 K, space group P21/c, Z = 4, μ(Mo-Kα) = 0.178
mm−1, 33195 reflections measured, 7769 unique (Rint =0.043), 5067
reflections used in the calculations [I > 3σ(I)], 379 parameters, R1 =
0.0418, wR2 = 0.0446.
(t, JCP = 25.8, C), 124.8 (s, CHar), 122.9 (t, JCP = 23.2 C), 121.1 (q, JCF
=
320.8, CF3SO3), 39.2 (CH3). 31P NMR (CD3CN, 25 °C): δ = +18.7
(d, JPRh = 135.7). 103Rh NMR (CD3CN, 25 °C): δ = −75 ppm.
MS(ES+): m/z 923.0 [M − CF3SO3−]+; HRMS(ES+) calcd for
C40H34N4O4F3P2SClRh, 923.0472; found, 923.0491. Elemental
analysis, calcd (%) for C41H34ClF6N4O7P2RhS2: C 45.89, H 3.19,
N 5.22; found: C 45.00, H 3.20, N 5.10.
Crystal data for 3: C40H34F6N4O6P2S2, M = 906.80 g·mol−1, mono-
clinic, a = 15.633(3), b = 22.942(5), c = 14.911(3) Å, β = 116.15(3)°,
V = 4800(2) Å3, T = 180 K, space group C2/c, Z = 4, μ(Mo-Kα) = 0.246
mm−1, 22578 reflections measured, 7462 unique (Rint =0.0659), 4905
reflections used in the calculations [I > 3σ(I)], 266 parameters, R1 =
0.1134, wR2 = 0.1073.
Rhodium(I)carbonyl Triflate Complex of the Ligand 3 (8). A
mixture of 5 (280 mg, 0.26 mmol) and silver trifluoromethanesulfonate
(74 mg, 0.29 mmol) cooled to −20 °C, was dissolved in MeCN
(10 mL). After warming up to room temperature, the solution was
stirred for 12 h. The solid was then filtered off, and the solution
evaporated under vacuum. After addition of THF (10 mL) and filtration
of the remaining solid, the solvent was removed under vacuum, affording
8 as a yellow solid (291 mg, 94%).
Crystal data for 5: C41H34ClF6N4O7P2RhS2, M = 1073.17 g·mol−1,
triclinic, a = 12.7519(12), b = 13.7106(13), c = 13.8297(13) Å, α =
77.390(4), β = 79.713(4), γ = 68.869(4)°, V = 2187.7(4) Å3, T = 180 K,
space group P1, Z = 2, μ(Mo-Kα) = 0.700 mm−1, 55848 reflections
̅
measured, 13792 unique (Rint = 0.021), 11019 reflections used in the
1H NMR (CD3CN, 25 °C): δ = 9.81 (br, 1H, Har), 8.26 (s, 2H, Har),
8.05 (s, 2H, Har), 7.77−7.38 (m, 23H, Har), 3.28 (s, 6H, NCH3). 13C
NMR (CD3CN, 25 °C): δ = 187.7 (d, JCRh = 70.4, CO), 138.5 (peudo-t,
J = 17.6, C), 135.9 (d, J = 46.5, C), 135.5 (s, C), 133.4 (s, CHar), 133.1 (s,
CHar), 132.0 (s, CHar), 131.7 (s, CHar), 130.8 (s, CHar), 130.4−130.3
(m, CHar), 129.5 (s, CHar), 124.3 (br, C), 121.0 (q, JCF = 320.8,
CF3SO3), 120.8 (br, C), 111.4 (s, CHar), 39.4 (CH3). 31P NMR
(CD3CN, 25 °C):δ = +12.4 (d, JPRh = 125.6). 103Rh NMR (CD3CN,
calculations [I > 3σ(I)], 577 parameters, R1 = 0.0299, wR2 = 0.0306.
COMPUTATIONAL DETAILS
■
Geometries were fully optimized at the PCM-B3PW91/6-31G**/
LANL2DZ*(Rh) level of calculation using Gaussian09.31 LANL2DZ*-
(Rh) means that f-polarization functions derived by Ehlers et al.32 for Rh
have been added to the LANL2DZ(Rh) basis set. Vibrational analysis
was performed at the same level as the geometry optimization. Solvent
effects were included using the polarizable continuum model (PCM)
implemented in Gaussian09 for acetonitrile (ε = 35.688). From these
optimized structures, the potential energy surface was explored along
the reaction coordinate (C1−H1 distance) at the same calculation level.
The intrinsic reaction coordinate was followed using the IRC technique
implemented in Gaussian 09 for all located transition states.
−
25 °C): δ = −138 ppm. MS(ES+):m/z 1037.0 [M − CF3SO3 ]+;
HRMS(ES+) calcd for C41H34N4O7F6P2RhS2, 1037.0303; found,
1037.0319. Elemental analysis, calcd (%) for C42H34F9N4O10P2RhS3:
C 42.51, H 2.89, N 4.72; found: C 37.90, H 2.84, N 4.76 (the low value
found for the carbon element might be due to residual silver).
Rhodium(I)carbonyl Aryl Complex 9. Complex 8 (80 mg, 0.067
mmol) was dissolved in dry methanol (2 mL). After stirring overnight
at room temperature, the solvent was then removed under vacuum.
After washing by Et2O (10 mL), 9 was obtained as a brown solid
(67 mg, 90%).
The magnetic shielding tensor was calculated at the B3PW91/6-
31+G**/LANL2DZ*(Rh) using the GIAO (gauge-independent atomic
orbital) method implemented in Gaussian09.31 The 31P NMR chemical
shifts were estimated with respect to the usual H3PO4 reference.
1H NMR (CD2Cl2, 25 °C): 9.59 (s, 1H, CH), 9.51 (s, 1H, CH), 8.35
(d, 1H, JHH = 5.0, Har), 8.11 (s, 1H, Har), 7.93 (brs, 2H, Har), 7.82−7.71
(m, 4H, Har), 7.65−7.63 (m, 3H, Har), 7.59−7.41 (m, 15H, Har), 6.84 (d,
1H, JHH = 1.9, Har), 4.13 (s, 3H, CH3N), 4.09 (s, 3H, CH3N), 3.47 (s,
NBO analysis33 was performed using NBO 5.G.34 In NBO analysis,
deviations from idealized Lewis structures are interpreted in terms of
donor−acceptor interactions between filled localized bonds or lone-
pairs (donors) and empty antibonds (acceptors). They are referred to as
“delocalization” corrections to the zeroth-order natural Lewis structure
and estimated by the second-order perturbation theory. The stabilization
6H, CH3O). 13C NMR (CD2Cl2, 25 °C): δ = 190.7 (td, JCRh = 57.8, JCP
=
16.3, CO), 177.0 (td, JCRh = 44.0, JCP = 17.6, C), 140.0 (s, C), 135.9 (s,
C), 135.8 (broad s, N2CH), 135.4 (broad s, N2CH), 135.3 (s, C), 133.6
I
dx.doi.org/10.1021/ic3006508 | Inorg. Chem. XXXX, XXX, XXX−XXX